Literature DB >> 17140706

Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones.

Oludotun A Phillips1, Edet E Udo, Ahmed A M Ali, Santhosh M Samuel.   

Abstract

A series of novel arylcarbonyl- and arylsulfonyl-piperazinyl 5-triazolylmethyl oxazolidinones were synthesized and tested against a panel of Gram-positive and Gram-negative bacterial clinical isolates. The arylcarbonyl oxazolidinone derivatives showed strong in vitro antibacterial activity against susceptible and resistant Gram-positive pathogenic bacteria and were more active than the arylsufonyl derivatives. Substitution of varied electron-withdrawing and electron-donating groups on the phenyl ring in the arylcarbonyl series did not alter antibacterial activity significantly. However, in the arylsufonyl series, methyl substitution on the phenyl ring resulted in the loss of antibacterial activity. Antibacterial activity could not be directly correlated with the calculated partition coefficient (ClogP) values in this series of compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140706     DOI: 10.1016/j.ejmech.2006.10.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.

Authors:  Cheng Ji; Weimin Lin; Garrett C Moraski; Jane A Thanassi; Michael J Pucci; Scott G Franzblau; Ute Möllmann; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-04-18       Impact factor: 3.641

2.  Syntheses and antibacterial activity studies of new oxazolidinones from nitroso Diels-Alder chemistry.

Authors:  Shanshan Yan; Marvin J Miller; Timothy A Wencewicz; Ute Möllmann
Journal:  Bioorg Med Chem Lett       Date:  2009-10-08       Impact factor: 2.823

3.  Antimycobacterial Activities of Novel 5-(1H-1,2,3-Triazolyl)Methyl Oxazolidinones.

Authors:  Oludotun Adebayo Phillips; Edet Ekpenyong Udo; Reny Varghese
Journal:  Tuberc Res Treat       Date:  2012-04-11

Review 4.  Current updates on oxazolidinone and its significance.

Authors:  Neha Pandit; Rajeev K Singla; Birendra Shrivastava
Journal:  Int J Med Chem       Date:  2012-02-26

5.  Comparative Pharmacokinetic Study for Linezolid and Two Novel Antibacterial Oxazolidinone Derivatives in Rabbits: Can Differences in the Pharmacokinetic Properties Explain the Discrepancies between Their In Vivo and In Vitro Antibacterial Activities?

Authors:  Mohsen A Hedaya; Vidhya Thomas; Mohamed E Abdel-Hamid; Elijah O Kehinde; Oludotun A Phillips
Journal:  Pharmaceutics       Date:  2017-09-07       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.